News1 min ago
Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference
—Brensocatib Reduced Risk of Exacerbations Irrespective of Disease Severity in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE) in Phase 2 WILLOW Subgroup Analysis— —Real-World Cohort Study Shows...